Patent expirations of key blockbuster drugs and efforts by payers to contain costs are likely to bring strong growth to the global generic drug market in the next few years as market-earned revenues grow by more than $100 billion, according to an analysis by research firm Frost & Sullivan.

Mylan has launched a generic drug for treating high blood pressure, the company said.

Teva Pharmaceutical Industries announced that Shlomo Yanai, president and CEO, will retire from his post in May.

Drug maker Actavis is partnering with QRxPharma to sell what the former called a novel pain drug in the United States.

A Pfizer painkiller appears to produce a much less positive experience for recreational drug users when crushed than when administered whole, according to results of a post-marketing clinical study program.

Ranbaxy Labs said Wednesday that it had resolved long-standing issues concerning two of its manufacturing plants in India with the U.S. government.

Israeli drug maker Teva Pharmaceutical Industries is developing a protein that could offer a new way to treat Type 1 diabetes, according to published reports.

The Food and Drug Administration has approved a drug made by Sandoz for treating yeast and other fungal infections.

According to two new surveys of parents and pediatricians from Pfizer Consumer Healthcare, more than half of all parents report feeling anxious, fearful or helpless when their child comes down with a fever.

The Food and Drug Administration has approved a generic painkiller made by Sun Pharmaceutical Industries, Sun said.

A Food and Drug Administration panel of 13 advisers has voted in favor of a drug made by Pfizer for treating kidney cancer, the drug maker said Wednesday.

The Food and Drug Administration will decide on Wednesday whether to remove merchandising restrictions on the emergency contraceptive Plan B and allow the product to be merchandised in the front-end without age restrictions, according to a report published Monday in the Washington Post.